Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 4
2(50.0%)
4Total
N/A(2)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT07193277Phase 4Recruiting

Butylphthalide for Cognitive Impairment in Elderly Patients With Focal Epilepsy

Role: collaborator

NCT07114120Phase 4Recruiting

Clinical Study on the Treatment of Stable Bronchiectasis With Bailing Capsules Combined With Guben Kechuan Granules

Role: collaborator

NCT06728839Not ApplicableNot Yet Recruiting

Efficacy, Safety and Tolerability of Magnesium Sulfate With Low-volume Polyethylene Glycol for Colonoscopy Cleansing

Role: collaborator

NCT06512688Recruiting

Establishing Reference Ranges for Fat-Soluble Vitamins in Healthy Chinese Adults

Role: collaborator

NCT05291325Not ApplicableCompleted

Application of Linaclotide Capsule in Bowel Preparation for Colonoscopy

Role: collaborator

NCT04915001Completed

An Investigation on the Role of Emergency Departments in Combatting Against COVID-19 in Zhejiang Province

Role: collaborator

NCT04915690Unknown

Investigation on the Practice Status of Emergency Stuff

Role: collaborator

NCT02094638Completed

Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study

Role: collaborator

All 8 trials loaded